A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome

Roche

Status: Completed

Conditions: Healthy Volunteer, Autistic Disorder, Asperger's Syndrome

Study type: Observational

Funder types: Industry

Identifiers

NCT01669889

BP28421

Details and patient eligibility

About

This multi-center, non-drug study will explore the relationship between exploratory biomarkers and functional dimensions in male adult individuals with Autistic Disorder or Asperger's Syndrome and healthy volunteer controls. Subjects will undergo a number of assessments on study visit Day 1.

Enrollment: 38 patients

Sex: Male

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Individuals with Autistic Disorder or Asperger's Syndrome:

• Male adults, 18 to 45 years of age inclusive
• Diagnosis of Autistic Disorder or Asperger's Syndrome as defined by DSM-IV
• IQ >70
• Body mass index (BMI) 18 to 35 kg/m2
• Availability of a reliable caregiver, able and willing to provide information regarding the individual's behavior and symptoms

Healthy controls:

• Healthy male adults, 18 to 45 years of age inclusive
• IQ >70
• Body mass index (BMI) 18 to 30 kg/m2

Exclusion criteria

General exclusion criteria:

• Positive test for drugs of abuse or alcohol
• Confirmed systolic blood pressure >140 or <90 mmHg, and diastolic blood pressure >90 or <50 mmHg
• Resting pulse rate >100 or <40 beats per minute
• Alcohol and/or substance abuse/dependence during the last 12 months
• Concomitant disease or condition that could interfere with, or treatment of which might interfere with, the conduct of the study, or that would, in the opinion of the investigator, pose an unacceptable risk to the subject in this study

Additionally for individuals with Autistic Disorder or Asperger's Syndrome:

• History of epilepsy/seizure disorder (except simple febrile seizures)

  • Significant disruptive, aggressive or self-injurious, or sexually inappropriate behavior during the last 3 months that in the opinion of the investigator might interfere with the conduct of the study

Additionally for healthy controls:

• Clinically significant abnormalities in laboratory test results
• History of or current psychiatric, neurological disorder or pervasive developmental disorder

Trial design

38 participants in 1 patient group

Cohort